Sector Statistics
- Companies above $2B with consistent data: 245
- Median P/E: 26.6 (vs. market 20.6, +28.8%)
- Median ROE: 8.4% (vs. market 12.0%, -29.8%)
- Average dividend yield: 0.5% (vs. market 1.8%, -71.9%)
- Average market cap: $35.4B
- Total market cap: $8.67T
Valuation verdict
34 cheap, 39 fairly priced, 33 expensive and 139 no verdict.
See the 34 cheap ones in the screener
Valuation verdict from each company page. "No verdict": cyclicals, distorted earnings, loss-making or page not yet computed.
Top 10 Lowest P/E
- Aurinia Pharmaceuticals Inc. (AUPH) — P/E 6.9 · ROE 59.0%
- Universal Health Services, Inc. (UHS) — P/E 7.2 · ROE 20.5%
- PTC Therapeutics, Inc. (PTCT) — P/E 8.9 · ROE n/s
- Acadia Pharmaceuticals Inc. (ACAD) — P/E 8.9 · ROE 32.4%
- Novo Nordisk A/S (NVO) — P/E 9.4 · ROE 59.1%
- Aveanna Healthcare Holdings Inc. (AVAH) — P/E 9.5 · ROE n/s
- Tenet Healthcare Corporation (THC) — P/E 9.9 · ROE 33.3%
- Organon & Co. (OGN) — P/E 10.0
- Solventum Corporation (SOLV) — P/E 10.7 · ROE 29.0%
- Cigna Corporation (CI) — P/E 11.2 · ROE 14.3%
Top 10 Dividend Payers
- Sanofi (SNY) — Dividend yield 11.8% · P/E 21.7
- Pfizer Inc. (PFE) — Dividend yield 6.2% · P/E 36.7
- Qiagen N.V. (QGEN) — Dividend yield 5.9% · P/E 22.9
- Novo Nordisk A/S (NVO) — Dividend yield 4.8% · P/E 9.4
- Organon & Co. (OGN) — Dividend yield 4.7% · P/E 10.0
- Bristol-Myers Squibb Company (BMY) — Dividend yield 4.1% · P/E 13.5
- Koninklijke Philips N.V. (PHG) — Dividend yield 4.0% · P/E 18.2
- GSK plc (GSK) — Dividend yield 3.8% · P/E 14.8
- Fresenius Medical Care AG & Co. KGaA (FMS) — Dividend yield 3.7% · P/E 12.1
- Takeda Pharmaceutical Company Limited (TAK) — Dividend yield 3.6% · P/E 49.4
Leading Industries
- Drug Manufacturers - General: 16 · $4.12T
- Biotechnology: 98 · $1.07T
- Medical - Diagnostics & Research: 23 · $839.2B
- Medical - Devices: 27 · $712.3B
- Medical - Healthcare Plans: 8 · $691.4B
- Medical - Instruments & Supplies: 19 · $377.6B
- Drug Manufacturers - Specialty & Generic: 14 · $242.3B
- Medical - Distribution: 4 · $228.9B
- Medical - Care Facilities: 20 · $219.8B
- Medical - Healthcare Information Services: 8 · $57.4B
- Medical - Specialties: 2 · $51.4B
- Medical - Pharmaceuticals: 5 · $48.5B
Top Companies by Market Cap
- Eli Lilly and Company (LLY) — Drug Manufacturers - General · P/E 38.4 · Valuation: cheap
- Johnson & Johnson (JNJ) — Drug Manufacturers - General · P/E 29.7 · Valuation: expensive
- AbbVie Inc. (ABBV) — Drug Manufacturers - General · P/E 74.0 · Valuation: expensive
- Merck & Co., Inc. (MRK) — Drug Manufacturers - General · P/E 115.4 · Valuation: fairly priced
- UnitedHealth Group Incorporated (UNH) — Medical - Healthcare Plans · P/E 23.9 · Valuation: fairly priced
- Novartis AG (NVS) — Drug Manufacturers - General · P/E 21.3 · Valuation: fairly priced
- AstraZeneca PLC (AZN) — Drug Manufacturers - General · P/E 23.4 · Valuation: cheap
- Thermo Fisher Scientific Inc. (TMO) — Medical - Diagnostics & Research · P/E 35.2 · Valuation: fairly priced
- Amgen Inc. (AMGN) — Drug Manufacturers - General · P/E 25.0 · Valuation: expensive
- Gilead Sciences, Inc. (GILD) — Drug Manufacturers - General
- Novo Nordisk A/S (NVO) — Drug Manufacturers - General · P/E 9.4 · Valuation: cheap
- Abbott Laboratories (ABT) — Medical - Devices · P/E 31.4 · Valuation: fairly priced
- Pfizer Inc. (PFE) — Drug Manufacturers - General · P/E 36.7
- Danaher Corporation (DHR) — Medical - Diagnostics & Research · P/E 38.0 · Valuation: fairly priced
- Intuitive Surgical, Inc. (ISRG) — Medical - Instruments & Supplies · P/E 44.6 · Valuation: cheap
- Vertex Pharmaceuticals Incorporated (VRTX) — Biotechnology · P/E 29.4
- Bristol-Myers Squibb Company (BMY) — Drug Manufacturers - General · P/E 13.5 · Valuation: cheap
- Medtronic plc (MDT) — Medical - Devices · P/E 21.3 · Valuation: cheap
- CVS Health Corp. (CVS) — Medical - Healthcare Plans · P/E 22.9 · Valuation: expensive
- McKesson Corporation (MCK) — Medical - Distribution · P/E 24.0 · Valuation: cheap
- Stryker Corporation (SYK) — Medical - Devices · P/E 28.5 · Valuation: cheap
- Sanofi (SNY) — Drug Manufacturers - General · P/E 21.7 · Valuation: expensive
- GSK plc (GSK) — Drug Manufacturers - General · P/E 14.8 · Valuation: expensive
- HCA Healthcare, Inc. (HCA) — Medical - Care Facilities · P/E 14.3 · Valuation: fairly priced
- Elevance Health Inc. (ELV) — Medical - Healthcare Plans · P/E 17.2 · Valuation: fairly priced
- Regeneron Pharmaceuticals, Inc. (REGN) — Biotechnology · P/E 17.6
- Moderna, Inc. (MRNA) — Biotechnology
- Cigna Corporation (CI) — Medical - Healthcare Plans · P/E 11.2 · Valuation: cheap
- Boston Scientific Corporation (BSX) — Medical - Devices · P/E 17.2 · Valuation: cheap
- Cencora, Inc. (COR) — Medical - Distribution · P/E 23.0 · Valuation: fairly priced
- Takeda Pharmaceutical Company Limited (TAK) — Drug Manufacturers - Specialty & Generic · P/E 49.4 · Valuation: expensive
- Natera, Inc. (NTRA) — Medical - Diagnostics & Research
- argenx SE (ARGX) — Biotechnology · P/E 33.5
- Cardinal Health, Inc. (CAH) — Medical - Distribution · P/E 31.6 · Valuation: fairly priced
- Edwards Lifesciences Corporation (EW) — Medical - Devices · P/E 48.9 · Valuation: fairly priced
- Becton, Dickinson and Company (BDX) — Medical - Instruments & Supplies · P/E 53.3 · Valuation: fairly priced
- Agilent Technologies, Inc. (A) — Medical - Diagnostics & Research · P/E 33.0 · Valuation: fairly priced
- Humana Inc. (HUM) — Medical - Healthcare Plans · P/E 36.8 · Valuation: expensive
- Teva Pharmaceutical Industries Limited (TEVA) — Drug Manufacturers - Specialty & Generic · P/E 62.4 · Valuation: expensive
- Revolution Medicines, Inc. (RVMD) — Biotechnology
- IQVIA Holdings Inc. (IQV) — Medical - Diagnostics & Research · P/E 32.0 · Valuation: fairly priced
- Waters Corporation (WAT) — Medical - Diagnostics & Research · P/E 106.0 · Valuation: fairly priced
- Illumina, Inc. (ILMN) — Medical - Diagnostics & Research · P/E 50.9 · Valuation: fairly priced
- IDEXX Laboratories, Inc. (IDXX) — Medical - Diagnostics & Research · P/E 36.7 · Valuation: fairly priced
- Haleon plc (HLN) — Drug Manufacturers - Specialty & Generic · P/E 18.1 · Valuation: cheap
- BeOne Medicines AG (ONC) — Biotechnology · P/E 26.3
- Biogen Inc. (BIIB) — Drug Manufacturers - General · P/E 38.9 · Valuation: fairly priced
- DexCom, Inc. (DXCM) — Medical - Devices · P/E 33.7 · Valuation: fairly priced
- ResMed Inc. (RMD) — Medical - Instruments & Supplies · P/E 21.0 · Valuation: cheap
- Centene Corp. (CNC) — Medical - Healthcare Plans
Frequently Asked Questions
How are sector averages calculated?
We compute average P/E, ROE, dividend yield, and market cap across all companies in the sector that are listed on NYSE, NASDAQ, or AMEX. Extreme outliers (e.g. negative or triple-digit P/E) are included in the simple average, so the median and distribution are often more informative than the mean.
How often is this page updated?
Underlying company data refreshes daily for the top 500 stocks by market cap and weekly for the broader universe. Valuation ratios are calculated from the most recent TTM (trailing twelve months) financial statements.
What makes a sector attractive?
There's no single answer — it depends on valuation relative to history, earnings momentum, interest rate regime, and sector-specific tailwinds. Compare current sector P/E to its 10-year average and look at earnings revisions to gauge where the tide is turning.